REFRACTORY OSTEOSARCOMA
Clinical trials for REFRACTORY OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for REFRACTORY OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: first test of donor cell therapy
Disease control Recruiting nowThis is a first-in-human safety study testing a new type of donor immune cell therapy for children whose neuroblastoma or osteosarcoma has come back or hasn't responded to standard treatments. The main goal is to find the safest dose of these cells when given alongside a combinat…
Matched conditions: REFRACTORY OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Two-Pronged attack tested for Tough-to-Treat bone cancer in young people
Disease control Recruiting nowThis study is testing a combination of two drugs, atezolizumab and cabozantinib, to see if they can help control advanced osteosarcoma (a type of bone cancer) in adolescents and young adults. The trial is for patients aged 12 and older whose cancer has come back or spread after s…
Matched conditions: REFRACTORY OSTEOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for tough bone cancers: experimental drug trial opens
Disease control Recruiting nowThis early-stage study is testing a new drug called tegavivint, combined with an existing chemotherapy (gemcitabine), for people whose osteosarcoma (a type of bone cancer) has come back or stopped responding to standard treatments. The main goal is to find the safest and most eff…
Matched conditions: REFRACTORY OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids with tough cancers: experimental drug trial opens
Disease control Recruiting nowThis study is testing a new drug called tegavivint in children, teens, and young adults whose solid tumors or lymphomas have come back or haven't responded to other treatments. The main goals are to find the safest dose, understand the side effects, and see if the drug can help s…
Matched conditions: REFRACTORY OSTEOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Scientists re-engineer Patient's own immune cells to fight incurable bone cancer
Disease control Recruiting nowThis early-stage trial is testing a new treatment called CAR T-cell therapy for patients with advanced osteosarcoma, a type of bone cancer that has come back or stopped responding to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better ta…
Matched conditions: REFRACTORY OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New hope for kids with tough cancers: trial tests Double-Team drug strategy
Disease control Recruiting nowThis study is testing two different drug combinations to find safe doses and see if they can help control cancer in children and young adults whose solid tumors have come back or haven't responded to treatment. In the first part, participants will be assigned to receive either On…
Matched conditions: REFRACTORY OSTEOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC